{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:30:12Z","timestamp":1786980612672,"version":"build-2736575974"},"reference-count":235,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T00:00:00Z","timestamp":1768694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-02015-0","type":"journal-article","created":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T01:52:51Z","timestamp":1768701171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Long non-coding RNAs and therapeutic resistance in multiple myeloma: from molecular insights to clinical applications"],"prefix":"10.1007","volume":"26","author":[{"given":"Mohamad Hosein","family":"Safari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najma","family":"Farahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Faghih Ojaroodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirali","family":"Ebrahimpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fateme","family":"Zare Khormizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Mafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasoul","family":"Raesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Mohammad-Sadeghipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Alimohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiavash","family":"Hushmandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Taheriazam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,18]]},"reference":[{"issue":"1","key":"2015_CR1","doi-asserted-by":"publisher","first-page":"2400363","DOI":"10.1002\/adtp.202400363","volume":"8","author":"B Wu","year":"2025","unstructured":"Wu B, Wang ZX, Xie H, Xie PL. Dimethyl fumarate augments anticancer activity of \u00e5ngstrom silver particles in myeloma cells through NRF2 activation. Adv Ther. 2025;8(1):2400363.","journal-title":"Adv Ther"},{"key":"2015_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.25259\/Cytojournal_64_2023","volume":"21","author":"J Zhang","year":"2024","unstructured":"Zhang J, Ding X, Ding X. Exploring the efficacy and safety of anti-BCMA chimeric antigen receptor T-cell therapy for multiple myeloma: systematic review and meta-analysis. CytoJournal. 2024;21:13.","journal-title":"CytoJournal"},{"key":"2015_CR3","doi-asserted-by":"crossref","unstructured":"Desai K, Iqbal S, Rather M, Thirumaran R. Has the survival in patients with multiple myeloma changed with the advent of latest treatments? American Society of Hematology Washington, DC; 2023.","DOI":"10.1182\/blood-2023-190103"},{"issue":"9","key":"2015_CR4","doi-asserted-by":"publisher","first-page":"e1406","DOI":"10.1634\/theoncologist.2020-0141","volume":"25","author":"H Ludwig","year":"2020","unstructured":"Ludwig H, Novis Durie S, Meckl A, Hinke A, Durie B. Multiple myeloma incidence and mortality around the globe; interrelations between health access and quality, economic resources, and patient empowerment. Oncologist. 2020;25(9):e1406\u201313.","journal-title":"Oncologist"},{"issue":"1","key":"2015_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41418-023-01236-8","volume":"31","author":"AJ Levine","year":"2024","unstructured":"Levine AJ, Carpten JD, Murphy M, Hainaut P. Exploring the genetic and molecular basis of differences in multiple myeloma of individuals of African and European descent. Cell Death Differ. 2024;31(1):1\u20138.","journal-title":"Cell Death Differ"},{"key":"2015_CR6","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1182\/blood-2023-191338","volume":"142","author":"D Gadhiya","year":"2023","unstructured":"Gadhiya D, Amin V, Kamani Y, Mahesh G, Kotak K, Ratheesh R, et al. Global burden and trends of multiple myeloma in High-Income North America countries between 1990\u20132019, with projections of deaths to 2040: A benchmarking analysis for the global burden of disease study 2019. Blood. 2023;142:2004.","journal-title":"Blood"},{"issue":"2","key":"2015_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3390\/cancers12020407","volume":"12","author":"V Pinto","year":"2020","unstructured":"Pinto V, Bergantim R, Caires HR, Seca H, Guimar\u00e3es JE, Vasconcelos MH. Multiple myeloma: available therapies and causes of drug resistance. Cancers. 2020;12(2):407.","journal-title":"Cancers"},{"issue":"6","key":"2015_CR8","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3390\/cells11060941","volume":"11","author":"J Zhou","year":"2022","unstructured":"Zhou J, Chng W-J. Biological hallmarks and emerging strategies to target STAT3 signaling in multiple myeloma. Cells. 2022;11(6):941.","journal-title":"Cells"},{"issue":"3","key":"2015_CR9","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.3390\/molecules28031438","volume":"28","author":"FA Ambrosio","year":"2023","unstructured":"Ambrosio FA, Costa G, Gallo Cantafio ME, Torcasio R, Trapasso F, Alcaro S, et al. Natural agents as novel potential source of proteasome inhibitors with anti-tumor activity: focus on multiple myeloma. Molecules. 2023;28(3):1438.","journal-title":"Molecules"},{"issue":"7","key":"2015_CR10","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.clml.2022.01.011","volume":"22","author":"M-A Dimopoulos","year":"2022","unstructured":"Dimopoulos M-A, Richardson P, Lonial S. Treatment options for patients with heavily pretreated relapsed and refractory multiple myeloma. Clin Lymphoma Myeloma Leuk. 2022;22(7):460\u201373.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"2015_CR11","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.3390\/ijms24043136","volume":"24","author":"F De Luca","year":"2023","unstructured":"De Luca F, Allegra A, Di Chio C, Previti S, Zappal\u00e0 M, Ettari R. Monoclonal antibodies: the greatest resource to treat multiple myeloma. Int J Mol Sci. 2023;24(4):3136.","journal-title":"Int J Mol Sci"},{"key":"2015_CR12","doi-asserted-by":"publisher","first-page":"30996","DOI":"10.34172\/bi.30996","volume":"15","author":"A Bemidinezhad","year":"2025","unstructured":"Bemidinezhad A, Abolhassani Y, Noroozi-Karimabad M, Gholami AA, Alalikhan A, Roshani R, et al. Revolutionizing cancer therapy: monoclonal antibodies in radiosensitization. BioImpacts: BI. 2025;15:30996.","journal-title":"BioImpacts: BI"},{"issue":"12","key":"2015_CR13","doi-asserted-by":"publisher","first-page":"5825","DOI":"10.21873\/anticanres.16090","volume":"42","author":"N Steiner","year":"2022","unstructured":"Steiner N, Schober P, Willenbacher W, Kircher B, Gunsilius E, Wolf D, et al. Autologous and allogeneic stem cell transplantation as salvage treatment options for relapsed\/refractory multiple myeloma: A single-center experience over 20 years. Anticancer Res. 2022;42(12):5825\u201332.","journal-title":"Anticancer Res"},{"issue":"24","key":"2015_CR14","doi-asserted-by":"publisher","first-page":"5738","DOI":"10.3390\/cancers15245738","volume":"15","author":"I Strassl","year":"2023","unstructured":"Strassl I, Nikoloudis A, Machherndl-Spandl S, Buxhofer-Ausch V, Binder M, Wipplinger D, et al. Allogeneic stem cell transplantation in multiple myeloma: risk factors and outcomes in the era of new therapeutic options\u2014A single-center experience. Cancers. 2023;15(24):5738.","journal-title":"Cancers"},{"issue":"1","key":"2015_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3892\/ijo.2016.3516","volume":"49","author":"SR Krishnan","year":"2016","unstructured":"Krishnan SR, Jaiswal R, Brown RD, Luk F, Bebawy M. Multiple myeloma and persistence of drug resistance in the age of novel drugs. Int J Oncol. 2016;49(1):33\u201350.","journal-title":"Int J Oncol"},{"issue":"6","key":"2015_CR16","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.3390\/cancers14061592","volume":"14","author":"O Faruq","year":"2022","unstructured":"Faruq O, Zhao D, Shrestha M, Vecchione A, Zacksenhaus E, Chang H. Targeting an MDM2\/MYC axis to overcome drug resistance in multiple myeloma. Cancers. 2022;14(6):1592.","journal-title":"Cancers"},{"key":"2015_CR17","doi-asserted-by":"publisher","first-page":"1155621","DOI":"10.3389\/fonc.2023.1155621","volume":"13","author":"M Matamala Montoya","year":"2023","unstructured":"Matamala Montoya M, van Slobbe GJ, Chang J-C, Zaal EA, Berkers CR. Metabolic changes underlying drug resistance in the multiple myeloma tumor microenvironment. Front Oncol. 2023;13:1155621.","journal-title":"Front Oncol"},{"issue":"2","key":"2015_CR18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3923\/ijp.2024.166.173","volume":"20","author":"L He","year":"2024","unstructured":"He L, Wu H, Sun Z, Zhang J. Inhibition of multiple myeloma growth by Wogonin involves mitochondrial apoptosis and G2\/M cycle arrest. Int J Pharmacol. 2024;20(2):166\u201373.","journal-title":"Int J Pharmacol"},{"issue":"22","key":"2015_CR19","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1182\/bloodadvances.2022007217","volume":"6","author":"C Schinke","year":"2022","unstructured":"Schinke C, Poos AM, Bauer M, John L, Johnson S, Deshpande S, et al. Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level. Blood Adv. 2022;6(22):5873\u201383.","journal-title":"Blood Adv"},{"key":"2015_CR20","doi-asserted-by":"crossref","unstructured":"Schinke C, Weinhold N, Delgado-Calle J. The role of the bone marrow microenvironment in multiple myeloma evolution and therapy. Frontiers Media SA; 2023. p. 1157555.","DOI":"10.3389\/fonc.2023.1157555"},{"issue":"2","key":"2015_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/cancers13020217","volume":"13","author":"A Garcia-Ortiz","year":"2021","unstructured":"Garcia-Ortiz A, Rodriguez-Garcia Y, Encinas J, Maroto-Martin E, Castellano E, Teixido J, et al. The role of tumor microenvironment in multiple myeloma development and progression. Cancers. 2021;13(2):217.","journal-title":"Cancers"},{"key":"2015_CR22","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3389\/fonc.2020.00636","volume":"10","author":"N Leblay","year":"2020","unstructured":"Leblay N, Maity R, Hasan F, Neri P. Deregulation of adaptive T cell immunity in multiple myeloma: insights into mechanisms and therapeutic opportunities. Front Oncol. 2020;10:636.","journal-title":"Front Oncol"},{"issue":"1","key":"2015_CR23","first-page":"341430","volume":"2015","author":"W-C Yang","year":"2015","unstructured":"Yang W-C, Lin S-F. Mechanisms of drug resistance in relapse and refractory multiple myeloma. Biomed Res Int. 2015;2015(1):341430.","journal-title":"Biomed Res Int"},{"key":"2015_CR24","first-page":"121","volume-title":"Cancer stem cells in multiple myeloma and the development of novel therapeutic strategies","author":"F Dammacco","year":"2019","unstructured":"Dammacco F, Leone P, Silvestris F, Racanelli V, Vacca A. Cancer stem cells in multiple myeloma and the development of novel therapeutic strategies. Oncogenomics: Elsevier; 2019. pp. 121\u201337."},{"issue":"7","key":"2015_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12032-024-02392-8","volume":"41","author":"SIS Al-Hawary","year":"2024","unstructured":"Al-Hawary SIS, Jasim SA, Altalbawy FM, Hjazi A, Jyothi SR, Kumar A, et al. Highlighting the role of long non-coding RNA (LncRNA) in multiple myeloma (MM) pathogenesis and response to therapy. Med Oncol. 2024;41(7):171.","journal-title":"Med Oncol"},{"issue":"10","key":"2015_CR26","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/jmedgenet-2015-103334","volume":"52","author":"X Qi","year":"2015","unstructured":"Qi X, Zhang D-H, Wu N, Xiao J-H, Wang X, Ma W. CeRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52(10):710\u20138.","journal-title":"J Med Genet"},{"issue":"1","key":"2015_CR27","doi-asserted-by":"publisher","first-page":"8141","DOI":"10.1038\/s41467-023-43974-w","volume":"14","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Huang C, Zhang C, Zhou Y, Zhao E, Zhang Y, et al. LncRNA MIR200CHG inhibits EMT in gastric cancer by stabilizing miR-200c from target-directed MiRNA degradation. Nat Commun. 2023;14(1):8141.","journal-title":"Nat Commun"},{"issue":"4","key":"2015_CR28","first-page":"328","volume":"141","author":"X Agirre","year":"2023","unstructured":"Agirre X. RROL LncRNA role in multiple myeloma. Blood. J Am Soc Hematol. 2023;141(4):328\u201330.","journal-title":"J Am Soc Hematol"},{"issue":"2","key":"2015_CR29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo C-J, Chen L-L, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96\u2013118.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"2015_CR30","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.3390\/cancers14092101","volume":"14","author":"P Ye","year":"2022","unstructured":"Ye P, Feng L, Shi S, Dong C. The mechanisms of lncRNA-mediated multidrug resistance and the clinical application prospects of LncRNAs in breast cancer. Cancers. 2022;14(9):2101.","journal-title":"Cancers"},{"issue":"10","key":"2015_CR31","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/cac2.12194","volume":"41","author":"X Meng","year":"2021","unstructured":"Meng X, Lou QY, Yang WY, Wang YR, Chen R, Wang L, et al. The role of non-coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential. Cancer Commun. 2021;41(10):981\u20131006.","journal-title":"Cancer Commun"},{"key":"2015_CR32","doi-asserted-by":"publisher","first-page":"1390300","DOI":"10.3389\/fphar.2024.1390300","volume":"15","author":"Z Gao","year":"2024","unstructured":"Gao Z, Luan X, Wang X, Han T, Li X, Li Z, et al. DNA damage response-related NcRNAs as regulators of therapy resistance in cancer. Front Pharmacol. 2024;15:1390300.","journal-title":"Front Pharmacol"},{"issue":"11","key":"2015_CR33","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/iub.2888","volume":"76","author":"M Ebrahimnezhad","year":"2024","unstructured":"Ebrahimnezhad M, Asl SH, Rezaie M, Molavand M, Yousefi B, Majidinia M, lncRNAs. New players of cancer drug resistance via targeting ABC transporters. IUBMB Life. 2024;76(11):883\u2013921.","journal-title":"IUBMB Life"},{"issue":"2","key":"2015_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12032-023-02263-8","volume":"41","author":"RO Saleh","year":"2024","unstructured":"Saleh RO, Al-Ouqaili MT, Ali E, Alhajlah S, Kareem AH, Shakir MN, et al. lncRNA-microRNA axis in cancer drug resistance: particular focus on signaling pathways. Med Oncol. 2024;41(2):52.","journal-title":"Med Oncol"},{"key":"2015_CR35","doi-asserted-by":"publisher","first-page":"1552773","DOI":"10.3389\/fonc.2025.1552773","volume":"15","author":"W Liu","year":"2025","unstructured":"Liu W, Wang W. LncRNA in gastric cancer drug resistance: Deciphering the therapeutic strategies. Front Oncol. 2025;15:1552773.","journal-title":"Front Oncol"},{"key":"2015_CR36","doi-asserted-by":"publisher","first-page":"1522491","DOI":"10.3389\/fonc.2024.1522491","volume":"14","author":"H Yan","year":"2025","unstructured":"Yan H, Jiang N, Li X, Lin C, Wang F, Zhang J, et al. Exosomal LncRNAs as diagnostic and therapeutic targets in multiple myeloma. Front Oncol. 2025;14:1522491.","journal-title":"Front Oncol"},{"issue":"10\u201311","key":"2015_CR37","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/carcin\/bgad053","volume":"44","author":"H Yan","year":"2023","unstructured":"Yan H, Gao S, Xu A, Zuo L, Zhang J, Zhao Y, et al. MALAT1 regulates network of microRNA-15a\/16\u2013VEGFA to promote tumorigenesis and angiogenesis in multiple myeloma. Carcinogenesis. 2023;44(10\u201311):760\u201372.","journal-title":"Carcinogenesis"},{"issue":"1","key":"2015_CR38","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1186\/s12885-023-11084-x","volume":"23","author":"Y Ren","year":"2023","unstructured":"Ren Y, Liu Y, He W, Zhao W, Pan J, Gao H, et al. Expression of NEAT1 can be used as a predictor for Dex resistance in multiple myeloma patients. BMC Cancer. 2023;23(1):630.","journal-title":"BMC Cancer"},{"issue":"1","key":"2015_CR39","doi-asserted-by":"publisher","first-page":"2164449","DOI":"10.1080\/16078454.2022.2164449","volume":"28","author":"T Chen","year":"2023","unstructured":"Chen T, Sun Z, Cui Y, Ji J, Li Y, Qu X. Identification of long noncoding RNA NEAT1 as a key gene involved in the extramedullary disease of multiple myeloma by bioinformatics analysis. Hematology. 2023;28(1):2164449.","journal-title":"Hematology"},{"key":"2015_CR40","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.cca.2018.02.019","volume":"480","author":"Y Pan","year":"2018","unstructured":"Pan Y, Chen H, Shen X, Wang X, Ju S, Lu M, et al. Serum level of long noncoding RNA H19 as a diagnostic biomarker of multiple myeloma. Clin Chim Acta. 2018;480:199\u2013205.","journal-title":"Clin Chim Acta"},{"key":"2015_CR41","doi-asserted-by":"publisher","first-page":"113080","DOI":"10.1016\/j.intimp.2024.113080","volume":"142","author":"Y Song","year":"2024","unstructured":"Song Y, Guo N, Zi F, Zheng J, Cheng J. LncRNA H19 plays a role in multiple myeloma via interacting with hnRNPA2B1 to stabilize BET proteins by targeting osteoclasts and osteoblasts. Int Immunopharmacol. 2024;142:113080.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"2015_CR42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s10238-025-01624-z","volume":"25","author":"G Wang","year":"2025","unstructured":"Wang G, Wu W, He D, Wang J, Kong H, Wu W. N6-methyladenosine-mediated upregulation of H19 promotes resistance to bortezomib by modulating the miR-184\/CARM1 axis in multiple myeloma. Clin Experimental Med. 2025;25(1):102.","journal-title":"Clin Experimental Med"},{"issue":"1","key":"2015_CR43","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/16078454.2021.1872275","volume":"26","author":"Y Yin","year":"2021","unstructured":"Yin Y, Yang W, Zhang L, Liu K, Luo Z. Long non-coding RNA ANRIL and its target MicroRNAs (microRNA-34a, microRNA-125a and microRNA-186) relate to risk stratification and prognosis in multiple myeloma. Hematology. 2021;26(1):160\u20139.","journal-title":"Hematology"},{"key":"2015_CR44","doi-asserted-by":"publisher","first-page":"106967","DOI":"10.1016\/j.leukres.2022.106967","volume":"123","author":"X Zang","year":"2022","unstructured":"Zang X, Wang J, Xia Y, Li J, Chen L, Gu Y, et al. LncRNA MEG3 promotes the sensitivity of bortezomib by inhibiting autophagy in multiple myeloma. Leuk Res. 2022;123:106967.","journal-title":"Leuk Res"},{"issue":"3","key":"2015_CR45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/17501911.2025.2453413","volume":"17","author":"N El-Khazragy","year":"2025","unstructured":"El-Khazragy N, Abdelrahman SE, Darwish A, Hemida EH. Combined replacement of lnc-MEG3 and miR-155 elicit tumor suppression in multiple myeloma. Epigenomics. 2025;17(3):167\u201377.","journal-title":"Epigenomics"},{"issue":"1","key":"2015_CR46","first-page":"1","volume":"1","author":"S Saki","year":"2024","unstructured":"Saki S. Advancements in genomic research: paving the way for future personalized medicine. Int J BioMed Insights. 2024;1(1):1\u201315.","journal-title":"Int J BioMed Insights"},{"key":"2015_CR47","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1360\/N972016-00728","volume":"61","author":"M Shi","year":"2016","unstructured":"Shi M, Chen Y, Zhang W, Xia X. The evolutionary mechanism of genome size. Chin Sci Bull. 2016;61:3188\u201395.","journal-title":"Chin Sci Bull"},{"key":"2015_CR48","unstructured":"Loor L. So Much Junk? The Complexities of the Human Genome."},{"key":"2015_CR49","doi-asserted-by":"publisher","first-page":"108198","DOI":"10.1016\/j.compbiomed.2024.108198","volume":"171","author":"H Gong","year":"2024","unstructured":"Gong H, Liu Z, Yuan C, Luo Y, Chen Y, Zhang J, et al. Identification of cuproptosis-related LncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinoma. Comput Biol Med. 2024;171:108198.","journal-title":"Comput Biol Med"},{"key":"2015_CR50","doi-asserted-by":"crossref","unstructured":"Jarroux J, Morillon A, Pinskaya M. History, discovery, and classification of LncRNAs. Long Non Coding RNA Biology. 2017;1008:1\u201346.","DOI":"10.1007\/978-981-10-5203-3_1"},{"issue":"2","key":"2015_CR51","doi-asserted-by":"publisher","first-page":"e202009045","DOI":"10.1083\/jcb.202009045","volume":"220","author":"MC Bridges","year":"2021","unstructured":"Bridges MC, Daulagala AC, Kourtidis A. LNCcation: LncRNA localization and function. J Cell Biol. 2021;220(2):e202009045.","journal-title":"J Cell Biol"},{"issue":"12","key":"2015_CR52","doi-asserted-by":"publisher","first-page":"a032151","DOI":"10.1101\/cshperspect.a032151","volume":"11","author":"P McDonel","year":"2019","unstructured":"McDonel P, Guttman M. Approaches for Understanding the mechanisms of long noncoding RNA regulation of gene expression. Cold Spring Harb Perspect Biol. 2019;11(12):a032151.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2015_CR53","doi-asserted-by":"crossref","unstructured":"Li Z, Zhao W, Wang M, Zhou X. The role of long noncoding RNAs in gene expression. Gene Expression Profiling Cancer. 2019:33.","DOI":"10.5772\/intechopen.81773"},{"issue":"8","key":"2015_CR54","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.1007\/s12035-023-03911-w","volume":"61","author":"X Wu","year":"2024","unstructured":"Wu X, Fu M, Ge C, Zhou H, Huang H, Zhong M, et al. m6A-Mediated upregulation of LncRNA CHASERR promotes the progression of glioma by modulating the miR-6893-3p\/TRIM14 axis. Mol Neurobiol. 2024;61(8):5418\u201340.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2015_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41568-020-00306-0","volume":"21","author":"GJ Goodall","year":"2021","unstructured":"Goodall GJ, Wickramasinghe VO. RNA in cancer. Nat Rev Cancer. 2021;21(1):22\u201336.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2015_CR56","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/ncrna7020036","volume":"7","author":"V Aliperti","year":"2021","unstructured":"Aliperti V, Skonieczna J, Cerase A. Long non-coding RNA (lncRNA) roles in cell biology, neurodevelopment and neurological disorders. Non-coding RNA. 2021;7(2):36.","journal-title":"Non-coding RNA"},{"key":"2015_CR57","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.molimm.2019.04.011","volume":"112","author":"S Dahariya","year":"2019","unstructured":"Dahariya S, Paddibhatla I, Kumar S, Raghuwanshi S, Pallepati A, Gutti RK. Long non-coding RNA: Classification, biogenesis and functions in blood cells. Mol Immunol. 2019;112:82\u201392.","journal-title":"Mol Immunol"},{"issue":"1","key":"2015_CR58","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.gpb.2015.09.006","volume":"14","author":"Y Fang","year":"2016","unstructured":"Fang Y, Fullwood MJ. Roles, functions, and mechanisms of long non-coding RNAs in cancer. Genom Proteom Bioinform. 2016;14(1):42\u201354.","journal-title":"Genom Proteom Bioinform"},{"key":"2015_CR59","doi-asserted-by":"publisher","first-page":"117647","DOI":"10.1016\/j.lfs.2020.117647","volume":"252","author":"K-T Jin","year":"2020","unstructured":"Jin K-T, Yao J-Y, Fang X-L, Di H, Ma Y-Y. Roles of LncRNAs in cancer: focusing on angiogenesis. Life Sci. 2020;252:117647.","journal-title":"Life Sci"},{"issue":"3","key":"2015_CR60","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ncrna.2018.03.001","volume":"3","author":"MM Balas","year":"2018","unstructured":"Balas MM, Johnson AM. Exploring the mechanisms behind long noncoding RNAs and cancer. Non-coding RNA Res. 2018;3(3):108\u201317.","journal-title":"Non-coding RNA Res"},{"key":"2015_CR61","doi-asserted-by":"publisher","first-page":"649619","DOI":"10.3389\/fgene.2021.649619","volume":"12","author":"A Chowdhary","year":"2021","unstructured":"Chowdhary A, Satagopam V, Schneider R. Long non-coding rnas: mechanisms, experimental, and computational approaches in identification, characterization, and their biomarker potential in cancer. Front Genet. 2021;12:649619.","journal-title":"Front Genet"},{"key":"2015_CR62","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fonc.2020.00048","volume":"10","author":"Y Luo","year":"2020","unstructured":"Luo Y, Yang J, Yu J, Liu X, Yu C, Hu J, et al. Long non-coding rnas: emerging roles in the immunosuppressive tumor microenvironment. Front Oncol. 2020;10:48.","journal-title":"Front Oncol"},{"issue":"1","key":"2015_CR63","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev-immunol-041015-055459","volume":"35","author":"MK Atianand","year":"2017","unstructured":"Atianand MK, Caffrey DR, Fitzgerald KA. Immunobiology of long noncoding RNAs. Annu Rev Immunol. 2017;35(1):177\u201398.","journal-title":"Annu Rev Immunol"},{"key":"2015_CR64","doi-asserted-by":"publisher","first-page":"1384342","DOI":"10.3389\/fonc.2024.1384342","volume":"14","author":"S Yousefnia","year":"2024","unstructured":"Yousefnia S. A comprehensive review on LncRNA LOXL1-AS1: molecular mechanistic pathways of LncRNA LOXL1-AS1 in tumorigenicity of cancer cells. Front Oncol. 2024;14:1384342.","journal-title":"Front Oncol"},{"key":"2015_CR65","doi-asserted-by":"publisher","first-page":"598817","DOI":"10.3389\/fonc.2020.598817","volume":"10","author":"N Gao","year":"2020","unstructured":"Gao N, Li Y, Li J, Gao Z, Yang Z, Li Y, et al. Long non-coding rnas: the regulatory mechanisms, research strategies, and future directions in cancers. Front Oncol. 2020;10:598817.","journal-title":"Front Oncol"},{"issue":"3","key":"2015_CR66","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1039\/D2MO00261B","volume":"19","author":"N Wang","year":"2023","unstructured":"Wang N, Zhao Q, Huang Y, Wen C, Li Y, Bao M, et al. Lnc-TMEM132D-AS1 as a potential therapeutic target for acquired resistance to osimertinib in non-small-cell lung cancer. Mol Omics. 2023;19(3):238\u201351.","journal-title":"Mol Omics"},{"issue":"7","key":"2015_CR67","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/s41416-020-0742-9","volume":"122","author":"A Acha-Sagredo","year":"2020","unstructured":"Acha-Sagredo A, Uko B, Pantazi P, Bediaga NG, Moschandrea C, Rainbow L, et al. Long non-coding RNA dysregulation is a frequent event in non-small cell lung carcinoma pathogenesis. Br J Cancer. 2020;122(7):1050\u20138.","journal-title":"Br J Cancer"},{"key":"2015_CR68","doi-asserted-by":"publisher","first-page":"1446937","DOI":"10.3389\/fimmu.2024.1446937","volume":"15","author":"A Arshi","year":"2024","unstructured":"Arshi A, Mahmoudi E, Raeisi F, Dehghan Tezerjani M, Bahramian E, Ahmed Y, et al. Exploring potential roles of long non-coding RNAs in cancer immunotherapy: a comprehensive review. Front Immunol. 2024;15:1446937.","journal-title":"Front Immunol"},{"issue":"3","key":"2015_CR69","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/bfgp\/elv047","volume":"15","author":"NI Rodr\u00edguez-Malav\u00e9","year":"2016","unstructured":"Rodr\u00edguez-Malav\u00e9 NI, Rao DS. Long noncoding RNAs in hematopoietic malignancies. Brief Funct Genomics. 2016;15(3):227\u201338.","journal-title":"Brief Funct Genomics"},{"issue":"36","key":"2015_CR70","doi-asserted-by":"publisher","first-page":"60605","DOI":"10.18632\/oncotarget.17303","volume":"8","author":"L Nobili","year":"2017","unstructured":"Nobili L, Ronchetti D, Taiana E, Neri A. Long non-coding RNAs in B-cell malignancies: a comprehensive overview. Oncotarget. 2017;8(36):60605.","journal-title":"Oncotarget"},{"issue":"23","key":"2015_CR71","first-page":"2327","volume":"138","author":"Y Qiu","year":"2021","unstructured":"Qiu Y, Xu M, Huang S. Long noncoding rnas: emerging regulators of normal and malignant hematopoiesis. Blood J Am Soc Hematol. 2021;138(23):2327\u201336.","journal-title":"Blood J Am Soc Hematol"},{"issue":"1","key":"2015_CR72","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12943-017-0692-x","volume":"16","author":"TR Fernando","year":"2017","unstructured":"Fernando TR, Contreras JR, Zampini M, Rodriguez-Malave NI, Alberti MO, Anguiano J, et al. The LncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia. Mol Cancer. 2017;16(1):126.","journal-title":"Mol Cancer"},{"issue":"24","key":"2015_CR73","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1007\/s00018-013-1423-0","volume":"70","author":"M Kitagawa","year":"2013","unstructured":"Kitagawa M, Kitagawa K, Kotake Y, Niida H, Ohhata T. Cell cycle regulation by long non-coding RNAs. Cell Mol Life Sci. 2013;70(24):4785\u201394.","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"2015_CR74","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.molcel.2010.03.021","volume":"38","author":"KL Yap","year":"2010","unstructured":"Yap KL, Li S, Mu\u00f1oz-Cabello AM, Raguz S, Zeng L, Mujtaba S, et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional Silencing of INK4a. Mol Cell. 2010;38(5):662\u201374.","journal-title":"Mol Cell"},{"issue":"9","key":"2015_CR75","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1038\/s41375-018-0067-3","volume":"32","author":"N Amodio","year":"2018","unstructured":"Amodio N, Stamato MA, Juli G, Morelli E, Fulciniti M, Manzoni M, et al. Drugging the LncRNA MALAT1 via LNA GapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity. Leukemia. 2018;32(9):1948\u201357.","journal-title":"Leukemia"},{"key":"2015_CR76","doi-asserted-by":"crossref","unstructured":"Hu Y, Fang J, Fang H, Li C, Liu S, Ondrejka SL, et al. Targeting the MALAT1\/PARP1\/LIG3 complex induces DNA damage and apoptosis in multiple myeloma mouse models. American Society of Hematology Washington, DC; 2017.","DOI":"10.1038\/s41375-018-0104-2"},{"issue":"3","key":"2015_CR77","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3892\/or.2017.5802","volume":"38","author":"J-L Huang","year":"2017","unstructured":"Huang J-L, Liu W, Tian L-H, Chai T-T, Liu Y, Zhang F, et al. Upregulation of long non-coding RNA MALAT-1 confers poor prognosis and influences cell proliferation and apoptosis in acute monocytic leukemia. Oncol Rep. 2017;38(3):1353\u201362.","journal-title":"Oncol Rep"},{"issue":"3","key":"2015_CR78","doi-asserted-by":"publisher","first-page":"e1003368","DOI":"10.1371\/journal.pgen.1003368","volume":"9","author":"V Tripathi","year":"2013","unstructured":"Tripathi V, Shen Z, Chakraborty A, Giri S, Freier SM, Wu X, et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet. 2013;9(3):e1003368.","journal-title":"PLoS Genet"},{"issue":"19","key":"2015_CR79","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1016\/j.febslet.2013.07.048","volume":"587","author":"F Yang","year":"2013","unstructured":"Yang F, Yi F, Han X, Du Q, Liang Z. MALAT-1 interacts with HnRNP C in cell cycle regulation. FEBS Lett. 2013;587(19):3175\u201381.","journal-title":"FEBS Lett"},{"issue":"1","key":"2015_CR80","doi-asserted-by":"publisher","first-page":"13749","DOI":"10.1038\/srep13749","volume":"5","author":"Y Wang","year":"2015","unstructured":"Wang Y, Wu P, Lin R, Rong L, Xue Y, Fang Y. LncRNA NALT interaction with NOTCH1 promoted cell proliferation in pediatric T cell acute lymphoblastic leukemia. Sci Rep. 2015;5(1):13749.","journal-title":"Sci Rep"},{"issue":"21","key":"2015_CR81","doi-asserted-by":"publisher","first-page":"18534","DOI":"10.18632\/oncotarget.4069","volume":"6","author":"JM Hughes","year":"2015","unstructured":"Hughes JM, Legnini I, Salvatori B, Masciarelli S, Marchioni M, Fazi F, et al. C\/EBP\u03b1-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia. Oncotarget. 2015;6(21):18534.","journal-title":"Oncotarget"},{"issue":"50","key":"2015_CR82","doi-asserted-by":"publisher","first-page":"82400","DOI":"10.18632\/oncotarget.12252","volume":"7","author":"LQ Wang","year":"2016","unstructured":"Wang LQ, Wong KY, Li ZH, Chim CS. Epigenetic Silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia. Oncotarget. 2016;7(50):82400.","journal-title":"Oncotarget"},{"issue":"4","key":"2015_CR83","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3233\/CBM-181405","volume":"23","author":"W Luo","year":"2018","unstructured":"Luo W, Yu H, Zou X, Ni X, Wei J. Long non-coding RNA taurine-upregulated gene 1 correlates with unfavorable prognosis in patients with refractory or relapsed acute myeloid leukemia treated by purine analogue based chemotherapy regimens. Cancer Biomarkers. 2018;23(4):485\u201394.","journal-title":"Cancer Biomarkers"},{"issue":"16","key":"2015_CR84","doi-asserted-by":"publisher","first-page":"12842","DOI":"10.18632\/oncotarget.24401","volume":"9","author":"A Garitano-Trojaola","year":"2018","unstructured":"Garitano-Trojaola A, San Jos\u00e9-En\u00e9riz E, Ezponda T, Unfried JP, Carrasco-Le\u00f3n A, Razquin N, et al. Deregulation of linc-PINT in acute lymphoblastic leukemia is implicated in abnormal proliferation of leukemic cells. Oncotarget. 2018;9(16):12842.","journal-title":"Oncotarget"},{"issue":"1","key":"2015_CR85","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13045-015-0223-4","volume":"8","author":"C Zeng","year":"2015","unstructured":"Zeng C, Yu X, Lai J, Yang L, Chen S, Li Y. Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia. J Hematol Oncol. 2015;8(1):126.","journal-title":"J Hematol Oncol"},{"key":"2015_CR86","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.biopha.2018.05.047","volume":"104","author":"Z Li","year":"2018","unstructured":"Li Z, Yang L, Liu X, Nie Z, Luo J. Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21. Biomed Pharmacother. 2018;104:181\u201392.","journal-title":"Biomed Pharmacother"},{"key":"2015_CR87","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.gene.2017.01.004","volume":"607","author":"Y Lu","year":"2017","unstructured":"Lu Y, Li Y, Chai X, Kang Q, Zhao P, Xiong J, et al. Long noncoding RNA HULC promotes cell proliferation by regulating PI3K\/AKT signaling pathway in chronic myeloid leukemia. Gene. 2017;607:41\u20136.","journal-title":"Gene"},{"issue":"5","key":"2015_CR88","first-page":"1054","volume":"7","author":"C Sun","year":"2017","unstructured":"Sun C, Luan S, Zhang G, Wang N, Shao H, Luan C. CEBPA-mediated upregulation of the LncRNA PLIN2 promotes the development of chronic myelogenous leukemia via the GSK3 and Wnt\/\u03b2-catenin signaling pathways. Am J Cancer Res. 2017;7(5):1054.","journal-title":"Am J Cancer Res"},{"issue":"10","key":"2015_CR89","first-page":"1824","volume":"121","author":"B Zhang","year":"2013","unstructured":"Zhang B, Li M, McDonald T, Holyoake TL, Moon RT, Campana D, et al. Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt\u2013\u03b2-catenin signaling. Blood J Am Soc Hematol. 2013;121(10):1824\u201338.","journal-title":"Blood J Am Soc Hematol"},{"issue":"1","key":"2015_CR90","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1089\/dna.2016.3533","volume":"36","author":"Y Xiao","year":"2017","unstructured":"Xiao Y, Jiao C, Lin Y, Chen M, Zhang J, Wang J, et al. LncRNA UCA1 contributes to Imatinib resistance by acting as a CeRNA against miR-16 in chronic myeloid leukemia cells. DNA Cell Biol. 2017;36(1):18\u201325.","journal-title":"DNA Cell Biol"},{"issue":"8","key":"2015_CR91","first-page":"1704","volume":"7","author":"B He","year":"2017","unstructured":"He B, Bai Y, Kang W, Zhang X, Jiang X. LncRNA SNHG5 regulates Imatinib resistance in chronic myeloid leukemia via acting as a CeRNA against MiR-205-5p. Am J Cancer Res. 2017;7(8):1704.","journal-title":"Am J Cancer Res"},{"issue":"4","key":"2015_CR92","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/10245332.2016.1258152","volume":"22","author":"H Wang","year":"2017","unstructured":"Wang H, Li Q, Tang S, Li M, Feng A, Qin L, et al. The role of long noncoding RNA HOTAIR in the acquired multidrug resistance to Imatinib in chronic myeloid leukemia cells. Hematology. 2017;22(4):208\u201316.","journal-title":"Hematology"},{"issue":"5","key":"2015_CR93","doi-asserted-by":"publisher","first-page":"490","DOI":"10.4062\/biomolther.2016.162","volume":"25","author":"X Zhou","year":"2017","unstructured":"Zhou X, Yuan P, Liu Q, Liu Z. LncRNA MEG3 regulates Imatinib resistance in chronic myeloid leukemia via suppressing microRNA-21. Biomolecules Ther. 2017;25(5):490.","journal-title":"Biomolecules Ther"},{"issue":"4","key":"2015_CR94","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.bbrc.2019.05.078","volume":"514","author":"F Nian","year":"2019","unstructured":"Nian F, Zhu J, Chang H. Long non-coding RNA ANGPTL1-3 promotes multiple myeloma bortezomib resistance by sponging miR-30a-3p to activate c-Maf expression. Biochem Biophys Res Commun. 2019;514(4):1140\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2015_CR95","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41419-018-1219-0","volume":"10","author":"Y Pan","year":"2019","unstructured":"Pan Y, Zhang Y, Liu W, Huang Y, Shen X, Jing R, et al. LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p. Cell Death Dis. 2019;10(2):106.","journal-title":"Cell Death Dis"},{"key":"2015_CR96","doi-asserted-by":"publisher","first-page":"bay039","DOI":"10.1093\/database\/bay039","volume":"2018","author":"F Yu","year":"2018","unstructured":"Yu F, Zhang G, Shi A, Hu J, Li F, Zhang X, et al. LnChrom: a resource of experimentally validated lncRNA\u2013chromatin interactions in human and mouse. Database. 2018;2018:bay039.","journal-title":"Database"},{"key":"2015_CR97","first-page":"3912","volume":"61","author":"C Chu","year":"2012","unstructured":"Chu C, Quinn J, Chang HY. Chromatin isolation by RNA purification (ChIRP). J Visualized Experiments: JoVE. 2012;61:3912.","journal-title":"J Visualized Experiments: JoVE"},{"key":"2015_CR98","doi-asserted-by":"crossref","unstructured":"Csorba T, Questa JI, Sun Q, Dean C. Antisense COOLAIR mediates the coordinated switching of chromatin states at FLC during vernalization. Proceedings of the National Academy of Sciences. 2014;111(45):16160\u20135.","DOI":"10.1073\/pnas.1419030111"},{"issue":"3","key":"2015_CR99","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/epigenomes3030014","volume":"3","author":"A Fiorenzano","year":"2019","unstructured":"Fiorenzano A, Pascale E, Patriarca EJ, Minchiotti G, Fico A. LncRNAs and PRC2: coupled partners in embryonic stem cells. Epigenomes. 2019;3(3):14.","journal-title":"Epigenomes"},{"issue":"22","key":"2015_CR100","doi-asserted-by":"publisher","first-page":"12900","DOI":"10.1111\/jcmm.15968","volume":"24","author":"C Zhang","year":"2020","unstructured":"Zhang C, Han B, Xu T, Li D. The biological function and potential mechanism of long non-coding RNAs in cardiovascular disease. J Cell Mol Med. 2020;24(22):12900\u20139.","journal-title":"J Cell Mol Med"},{"key":"2015_CR101","doi-asserted-by":"publisher","first-page":"1429411","DOI":"10.3389\/fgene.2024.1429411","volume":"15","author":"H Xiao","year":"2024","unstructured":"Xiao H, Ma C, Peng R, Xie M. Insights into the role of non-coding RNAs in the development of insecticide resistance in insects. Front Genet. 2024;15:1429411.","journal-title":"Front Genet"},{"issue":"4","key":"2015_CR102","doi-asserted-by":"publisher","first-page":"422","DOI":"10.30699\/ijp.2024.2022061.3256","volume":"19","author":"L Sarafraznia","year":"2024","unstructured":"Sarafraznia L, Asadi ZTN, Dayer D, Jalalifar MA, Ghanatir N. Investigation of Non-Coding RNA-Related autophagy alterations in Drug-Resistant multiple myeloma plasma cells. Iran J Pathol. 2024;19(4):422.","journal-title":"Iran J Pathol"},{"key":"2015_CR103","unstructured":"Chen C, Picard D, Qin N, Schipp C, Gombert M, Ginzel S, et al. The landscape of circular RNAs in drug resistant TCF3-Rearranged childhood leukemia. American Society of Hematology Washington, DC; 2017."},{"issue":"26","key":"2015_CR104","doi-asserted-by":"publisher","first-page":"6502","DOI":"10.7150\/jca.35098","volume":"10","author":"X Shen","year":"2019","unstructured":"Shen X, Shen P, Yang Q, Yin Q, Wang F, Cong H, et al. Knockdown of long non-coding RNA PCAT-1 inhibits myeloma cell growth and drug resistance via p38 and JNK MAPK pathways. J Cancer. 2019;10(26):6502.","journal-title":"J Cancer"},{"key":"2015_CR105","doi-asserted-by":"crossref","unstructured":"Li-Hui Y, Peng D, Wei L, Li-Kun A, Jian L, Wen-Yi Z et al. LncRNA ANRIL promotes multiple myeloma progression and bortezomib resistance by EZH2-mediated epigenetically Silencing of PTEN. Neoplasma. 2021;68(4): 788-797.","DOI":"10.4149\/neo_2021_210205N184"},{"key":"2015_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-015-0219-5","volume":"34","author":"M Zhou","year":"2015","unstructured":"Zhou M, Zhao H, Wang Z, Cheng L, Yang L, Shi H, et al. Identification and validation of potential prognostic LncRNA biomarkers for predicting survival in patients with multiple myeloma. J Experimental Clin Cancer Res. 2015;34:1\u201314.","journal-title":"J Experimental Clin Cancer Res"},{"key":"2015_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12920-019-0577-5","volume":"12","author":"M Lu","year":"2019","unstructured":"Lu M, Hu Y, Wu Y, Zhou H, Jian Y, Tian Y, et al. Genome-wide discovery and characterization of long noncoding RNAs in patients with multiple myeloma. BMC Med Genom. 2019;12:1\u201316.","journal-title":"BMC Med Genom"},{"issue":"6","key":"2015_CR108","doi-asserted-by":"publisher","first-page":"76","DOI":"10.14715\/cmb\/2020.66.6.14","volume":"66","author":"Y Wang","year":"2020","unstructured":"Wang Y, Xu S, Wang L, Liu J, Wang J, Zhou J. Long noncoding RNA H19 promotes vincristine resistance in multiple myeloma by targeting Akt. Cell Mol Biol. 2020;66(6):76\u201380.","journal-title":"Cell Mol Biol"},{"key":"2015_CR109","doi-asserted-by":"publisher","first-page":"110058","DOI":"10.1016\/j.intimp.2023.110058","volume":"119","author":"N Guo","year":"2023","unstructured":"Guo N, Song Y, Zi F, Zheng J, Cheng J. Abnormal expression pattern of LncRNA H19 participates in multiple myeloma bone disease by unbalancing osteogenesis and osteolysis. Int Immunopharmacol. 2023;119:110058.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"2015_CR110","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00432-020-03127-8","volume":"146","author":"N Liu","year":"2020","unstructured":"Liu N, Feng S, Li H, Chen X, Bai S, Liu Y. Long non-coding RNA MALAT1 facilitates the tumorigenesis, invasion and Glycolysis of multiple myeloma via miR-1271-5p\/SOX13 axis. J Cancer Res Clin Oncol. 2020;146(2):367\u201379.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"2015_CR111","doi-asserted-by":"publisher","first-page":"e22008","DOI":"10.1002\/jbt.22008","volume":"32","author":"Y Wu","year":"2018","unstructured":"Wu Y, Wang H. LncRNA NEAT1 promotes dexamethasone resistance in multiple myeloma by targeting miR-193a\/MCL1 pathway. J Biochem Mol Toxicol. 2018;32(1):e22008.","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"2015_CR112","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000492846","volume":"49","author":"X Shen","year":"2018","unstructured":"Shen X, Bai H, Zhu H, Yan Q, Yang Y, Yu W, et al. Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate HOXA11 expression by sponging miR-181a in multiple myeloma. Cell Physiol Biochem. 2018;49(1):87\u2013100.","journal-title":"Cell Physiol Biochem"},{"issue":"6","key":"2015_CR113","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1111\/jcmm.15035","volume":"24","author":"X Shen","year":"2020","unstructured":"Shen X, Kong S, Yang Q, Yin Q, Cong H, Wang X, et al. PCAT-1 promotes cell growth by sponging miR\u2010129 via MAP3K7\/NF\u2010\u03baB pathway in multiple myeloma. J Cell Mol Med. 2020;24(6):3492\u2013503.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2015_CR114","doi-asserted-by":"publisher","first-page":"e2569","DOI":"10.1038\/cddis.2016.438","volume":"8","author":"F Peng","year":"2018","unstructured":"Peng F, Li T-T, Wang K-L, Xiao G-Q, Wang J-H, Zhao H-D, et al. H19\/let-7\/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance. Cell Death Dis. 2018;8(1):e2569\u2013e.","journal-title":"Cell Death Dis"},{"issue":"2","key":"2015_CR115","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/ijms18020450","volume":"18","author":"L Zhang","year":"2017","unstructured":"Zhang L, Zhou Y, Huang T, Cheng AS, Yu J, Kang W, et al. The interplay of LncRNA-H19 and its binding partners in physiological process and gastric carcinogenesis. Int J Mol Sci. 2017;18(2):450.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2015_CR116","doi-asserted-by":"publisher","first-page":"7491","DOI":"10.1038\/s41598-017-07611-z","volume":"7","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Gao W, Long Q-Q, Zhang J, Li Y-F, Liu D-C, et al. Increased plasma levels of LncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population. Sci Rep. 2017;7(1):7491.","journal-title":"Sci Rep"},{"issue":"6","key":"2015_CR117","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.3892\/or.2015.3899","volume":"33","author":"H Sun","year":"2015","unstructured":"Sun H, Wang G, Peng Y, Zeng Y, Zhu Q-N, Li T-L, et al. H19 LncRNA mediates 17\u03b2-estradiol-induced cell proliferation in MCF-7 breast cancer cells. Oncol Rep. 2015;33(6):3045\u201352.","journal-title":"Oncol Rep"},{"issue":"6","key":"2015_CR118","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.7314\/APJCP.2014.15.6.2565","volume":"15","author":"J Lv","year":"2014","unstructured":"Lv J, Yu Y-Q, Li S-Q, Luo L, Wang Q. Aflatoxin B1 promotes cell growth and invasion in hepatocellular carcinoma HepG2 cells through H19 and E2F1. Asian Pac J Cancer Prev. 2014;15(6):2565\u201370.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2015_CR119","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ejmech.2018.01.076","volume":"146","author":"Y Wan","year":"2018","unstructured":"Wan Y, Dai N, Tang Z, Fang H. Small-molecule Mcl-1 inhibitors: emerging anti-tumor agents. Eur J Med Chem. 2018;146:471\u201382.","journal-title":"Eur J Med Chem"},{"key":"2015_CR120","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10549-018-4697-y","volume":"169","author":"RL Costa","year":"2018","unstructured":"Costa RL, Han HS, Gradishar WJ. Targeting the PI3K\/AKT\/mTOR pathway in triple-negative breast cancer: a review. Breast Cancer Res Treat. 2018;169:397\u2013406.","journal-title":"Breast Cancer Res Treat"},{"key":"2015_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.intimp.2018.04.016","volume":"60","author":"L Wei","year":"2018","unstructured":"Wei L, Chen Q, Guo A, Fan J, Wang R, Zhang H. Asiatic acid attenuates CCl4-induced liver fibrosis in rats by regulating the PI3K\/AKT\/mTOR and Bcl-2\/Bax signaling pathways. Int Immunopharmacol. 2018;60:1\u20138.","journal-title":"Int Immunopharmacol"},{"key":"2015_CR122","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00441-017-2765-y","volume":"372","author":"L He","year":"2018","unstructured":"He L, Wang X, Kang N, Xu J, Dai N, Xu X, et al. MiR-375 inhibits the hepatocyte growth factor-elicited migration of mesenchymal stem cells by downregulating Akt signaling. Cell Tissue Res. 2018;372:99\u2013114.","journal-title":"Cell Tissue Res"},{"key":"2015_CR123","doi-asserted-by":"crossref","unstructured":"O\u2019Donnell JS, Massi D, Teng MW, Mandala M, editors. PI3K-AKT-mTOR Inhibition in cancer immunotherapy, redux. Seminars in cancer biology. Elsevier; 2018.","DOI":"10.1016\/j.semcancer.2017.04.015"},{"issue":"12","key":"2015_CR124","doi-asserted-by":"publisher","first-page":"14814","DOI":"10.18632\/oncotarget.7442","volume":"7","author":"D Ronchetti","year":"2016","unstructured":"Ronchetti D, Agnelli L, Taiana E, Galletti S, Manzoni M, Todoerti K, et al. Distinct LncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma. Oncotarget. 2016;7(12):14814.","journal-title":"Oncotarget"},{"issue":"6","key":"2015_CR125","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.2337\/db14-1117","volume":"64","author":"F Hu","year":"2015","unstructured":"Hu F, Wang M, Xiao T, Yin B, He L, Meng W, et al. miR-30 promotes thermogenesis and the development of beige fat by targeting RIP140. Diabetes. 2015;64(6):2056\u201368.","journal-title":"Diabetes"},{"issue":"1","key":"2015_CR126","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1158\/2159-8290.CD-13-0291","volume":"4","author":"LK Mathew","year":"2014","unstructured":"Mathew LK, Lee SS, Skuli N, Rao S, Keith B, Nathanson KL, et al. Restricted expression of miR-30c-2-3p and miR-30a-3p in clear cell renal cell carcinomas enhances HIF2\u03b1 activity. Cancer Discov. 2014;4(1):53\u201360.","journal-title":"Cancer Discov"},{"issue":"11","key":"2015_CR127","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.ejso.2013.11.008","volume":"40","author":"W Wang","year":"2014","unstructured":"Wang W, Lin H, Zhou L, Zhu Q, Gao S, Xie H, et al. MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma. Eur J Surg Oncol (EJSO). 2014;40(11):1586\u201394.","journal-title":"Eur J Surg Oncol (EJSO)"},{"key":"2015_CR128","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fendo.2018.00405","volume":"9","author":"Y Kong","year":"2018","unstructured":"Kong Y, Hsieh C-H, Alonso LC. ANRIL: a LncRNA at the CDKN2A\/B locus with roles in cancer and metabolic disease. Front Endocrinol. 2018;9:405.","journal-title":"Front Endocrinol"},{"key":"2015_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-018-0879-9","volume":"17","author":"L-Y Sun","year":"2018","unstructured":"Sun L-Y, Li X-J, Sun Y-M, Huang W, Fang K, Han C, et al. LncRNA ANRIL regulates AML development through modulating the glucose metabolism pathway of AdipoR1\/AMPK\/SIRT1. Mol Cancer. 2018;17:1\u20136.","journal-title":"Mol Cancer"},{"issue":"1","key":"2015_CR130","doi-asserted-by":"publisher","first-page":"112280","DOI":"10.1016\/j.yexcr.2020.112280","volume":"396","author":"M Wang","year":"2020","unstructured":"Wang M, Zhao H-y, Zhang J-l, Wan D-m, Li Y-m, Jiang Z-x. Dysregulation of LncRNA ANRIL mediated by miR-411\u20133p inhibits the malignant proliferation and tumor stem cell like property of multiple myeloma via hypoxia-inducible factor 1\u03b1. Exp Cell Res. 2020;396(1):112280.","journal-title":"Exp Cell Res"},{"key":"2015_CR131","doi-asserted-by":"crossref","unstructured":"Aguilo F, Di Cecilia S, Walsh MJ. Long non-coding RNA ANRIL and polycomb in human cancers and cardiovascular disease. Long Non-coding RNAs in human disease. Curr Top Microbiol Immunol. 2016;394:29\u201339.","DOI":"10.1007\/82_2015_455"},{"issue":"3","key":"2015_CR132","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3233\/CBM-170683","volume":"21","author":"B Zhao","year":"2018","unstructured":"Zhao B, Lu Y-L, Yang Y, Hu L-B, Bai Y, Li R-Q, et al. Overexpression of LncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a\/TGF-\u03b21\/Smad signaling pathway. Cancer Biomarkers. 2018;21(3):613\u201320.","journal-title":"Cancer Biomarkers"},{"issue":"10","key":"2015_CR133","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/CAD.0000000000000807","volume":"30","author":"Y Ma","year":"2019","unstructured":"Ma Y, Zhang H, Li G, Hu J, Liu X, Lin L. LncRNA ANRIL promotes cell growth, migration and invasion of hepatocellular carcinoma cells via sponging miR-144. Anticancer Drugs. 2019;30(10):1013\u201321.","journal-title":"Anticancer Drugs"},{"key":"2015_CR134","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11010-015-2618-5","volume":"412","author":"M Naemura","year":"2016","unstructured":"Naemura M, Tsunoda T, Inoue Y, Okamoto H, Shirasawa S, Kotake Y. ANRIL regulates the proliferation of human colorectal cancer cells in both two-and three-dimensional culture. Mol Cell Biochem. 2016;412:141\u20136.","journal-title":"Mol Cell Biochem"},{"issue":"5","key":"2015_CR135","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2217\/bmm-2016-0378","volume":"11","author":"M Taheri","year":"2017","unstructured":"Taheri M, Pouresmaeili F, Omrani MD, Habibi M, Sarrafzadeh S, Noroozi R, et al. Association of ANRIL gene polymorphisms with prostate cancer and benign prostatic hyperplasia in an Iranian population. Biomark Med. 2017;11(5):413\u201322.","journal-title":"Biomark Med"},{"issue":"12","key":"2015_CR136","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/genes11121505","volume":"11","author":"V Petkevicius","year":"2020","unstructured":"Petkevicius V, Streleckiene G, Balciute K, Link A, Leja M, Malfertheiner P, et al. Association of long non-coding RNA polymorphisms with gastric cancer and atrophic gastritis. Genes. 2020;11(12):1505.","journal-title":"Genes"},{"issue":"12","key":"2015_CR137","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1002\/mc.23110","volume":"58","author":"Y Deng","year":"2019","unstructured":"Deng Y, Zhou L, Li N, Wang M, Yao L, Dong S, et al. Impact of four LncRNA polymorphisms (rs2151280, rs7763881, rs1136410, and rs3787016) on glioma risk and prognosis: A case-control study. Mol Carcinog. 2019;58(12):2218\u201329.","journal-title":"Mol Carcinog"},{"issue":"7","key":"2015_CR138","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1158\/1541-7786.MCR-15-0418","volume":"14","author":"D Meseure","year":"2016","unstructured":"Meseure D, Vacher S, Alsibai KD, Nicolas A, Chemlali W, Caly M, et al. Expression of ANRIL\u2013polycomb complexes\u2013CDKN2A\/B\/ARF genes in breast tumors: identification of a two-gene (EZH2\/CBX7) signature with independent prognostic value. Mol Cancer Res. 2016;14(7):623\u201333.","journal-title":"Mol Cancer Res"},{"issue":"183","key":"2015_CR139","doi-asserted-by":"publisher","first-page":"721","DOI":"10.24976\/Discov.Med.202436183.68","volume":"36","author":"Y Wang","year":"2024","unstructured":"Wang Y, Tian J, Huang D, Gao Y, Lin H, Liu L, et al. EZH2 promotes multiple myeloma progression via STAT3 pathway activation. Discov Med. 2024;36(183):721\u20139.","journal-title":"Discov Med"},{"key":"2015_CR140","first-page":"1","volume":"20","author":"G Li","year":"2020","unstructured":"Li G, Gao L, Zhao J, Liu D, Li H, Hu M. LncRNA ANRIL\/miR-7-5p\/TCF4 axis contributes to the progression of T cell acute lymphoblastic leukemia. Cancer Cell Int. 2020;20:1\u201312.","journal-title":"Cancer Cell Int"},{"issue":"7","key":"2015_CR141","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1002\/mc.22626","volume":"56","author":"MJ Poi","year":"2017","unstructured":"Poi MJ, Li J, Sborov DW, VanGundy Z, Cho YK, Lamprecht M, et al. Polymorphism in ANRIL is associated with relapse in patients with multiple myeloma after autologous stem cell transplant. Mol Carcinog. 2017;56(7):1722\u201332.","journal-title":"Mol Carcinog"},{"issue":"3","key":"2015_CR142","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3892\/ijo.2017.4066","volume":"51","author":"Y Xu","year":"2017","unstructured":"Xu Y, Zheng Y, Liu H, Li T. Modulation of IGF2BP1 by long non-coding RNA HCG11 suppresses apoptosis of hepatocellular carcinoma cells via MAPK signaling transduction. Int J Oncol. 2017;51(3):791\u2013800.","journal-title":"Int J Oncol"},{"key":"2015_CR143","doi-asserted-by":"publisher","first-page":"112210","DOI":"10.1016\/j.biopha.2021.112210","volume":"143","author":"X Yuan","year":"2021","unstructured":"Yuan X, Zhao Q, Zhang Y, Xue M. The role and mechanism of HLA complex group 11 in cancer. Biomed Pharmacother. 2021;143:112210.","journal-title":"Biomed Pharmacother"},{"key":"2015_CR144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-019-1046-0","volume":"19","author":"H Zhang","year":"2019","unstructured":"Zhang H, Huang H, Xu X, Wang H, Wang J, Yao Z, et al. LncRNA HCG11 promotes proliferation and migration in gastric cancer via targeting miR-1276\/CTNNB1 and activating Wnt signaling pathway. Cancer Cell Int. 2019;19:1\u201312.","journal-title":"Cancer Cell Int"},{"key":"2015_CR145","doi-asserted-by":"publisher","first-page":"116948","DOI":"10.1016\/j.bcp.2025.116948","volume":"237","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wang X, Luo H, Liu X, Huang J, Mi Z, et al. LncRNA HCG11 regulates Selinexor sensitivity in multiple myeloma. Biochem Pharmacol. 2025;237:116948.","journal-title":"Biochem Pharmacol"},{"key":"2015_CR146","doi-asserted-by":"publisher","first-page":"216486","DOI":"10.1016\/j.canlet.2023.216486","volume":"580","author":"X Wang","year":"2024","unstructured":"Wang X, Xu J, Li Q, Zhang Y, Lin Z, Zhai X, et al. RNA-binding protein HnRNPU regulates multiple myeloma resistance to Selinexor. Cancer Lett. 2024;580:216486.","journal-title":"Cancer Lett"},{"issue":"1","key":"2015_CR147","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/leu.2013.115","volume":"28","author":"Y Tai","year":"2014","unstructured":"Tai Y, Landesman Y, Acharya C, Calle Y, Zhong M, Cea M, et al. CRM1 Inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications. Leukemia. 2014;28(1):155\u201365.","journal-title":"Leukemia"},{"key":"2015_CR148","doi-asserted-by":"publisher","first-page":"537763","DOI":"10.3389\/fonc.2020.537763","volume":"10","author":"C Ding","year":"2020","unstructured":"Ding C, Yi X, Xu J, Huang Z, Bu X, Wang D, et al. Long non-coding RNA MEG3 modifies cell-cycle, migration, invasion, and proliferation through AKAP12 by sponging miR-29c in meningioma cells. Front Oncol. 2020;10:537763.","journal-title":"Front Oncol"},{"issue":"1","key":"2015_CR149","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41419-021-04470-5","volume":"13","author":"S Zhang","year":"2021","unstructured":"Zhang S, Ji W-W, Wei W, Zhan L-X, Huang X. Long noncoding RNA Meg3 sponges miR-708 to inhibit intestinal tumorigenesis via SOCS3-repressed cancer stem cells growth. Cell Death Dis. 2021;13(1):25.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2015_CR150","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/jcmm.15759","volume":"25","author":"L Lin","year":"2021","unstructured":"Lin L, Liu X, Lv B. Long non-coding RNA MEG3 promotes autophagy and apoptosis of nasopharyngeal carcinoma cells via PTEN up\u2010regulation by binding to microRNA\u201021. J Cell Mol Med. 2021;25(1):61\u201372.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"2015_CR151","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/ijlh.13225","volume":"42","author":"Y Yu","year":"2020","unstructured":"Yu Y, Kou D, Liu B, Huang Y, Li S, Qi Y, et al. LncRNA MEG3 contributes to drug resistance in acute myeloid leukemia by positively regulating ALG9 through sponging miR-155. Int J Lab Hematol. 2020;42(4):464\u201372.","journal-title":"Int J Lab Hematol"},{"issue":"3","key":"2015_CR152","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.3892\/mmr.2017.6897","volume":"16","author":"B Ma","year":"2017","unstructured":"Ma B, Gao Z, Lou J, Zhang H, Yuan Z, Wu Q, et al. Long non\u2013coding RNA MEG3 contributes to cisplatin\u2013induced apoptosis via Inhibition of autophagy in human glioma cells. Mol Med Rep. 2017;16(3):2946\u201352.","journal-title":"Mol Med Rep"},{"key":"2015_CR153","unstructured":"Xia H, Qu X-L, Liu L-Y, Qian D-H, Jing H-Y. LncRNA MEG3 promotes the sensitivity of vincristine by inhibiting autophagy in lung cancer chemotherapy. Eur Rev Med Pharmacol Sci. 2018;22(4):1020-1027."},{"key":"2015_CR154","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.gene.2017.08.001","volume":"630","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Liu T, Wang K, Qu X, Pang Z, Liu S, et al. Down-regulation of long non-coding RNA MEG3 indicates an unfavorable prognosis in non-small cell lung cancer: evidence from the GEO database. Gene. 2017;630:49\u201358.","journal-title":"Gene"},{"issue":"28","key":"2015_CR155","doi-asserted-by":"publisher","first-page":"45918","DOI":"10.18632\/oncotarget.17439","volume":"8","author":"J Fang","year":"2017","unstructured":"Fang J, Qiao F, Tu J, Xu J, Ding F, Liu Y, et al. High expression of long non-coding RNA NEAT1 indicates poor prognosis of human cancer. Oncotarget. 2017;8(28):45918.","journal-title":"Oncotarget"},{"issue":"16","key":"2015_CR156","first-page":"3373","volume":"20","author":"Z Chen","year":"2016","unstructured":"Chen Z, Zhang Z, Xie B, Zhang H. Clinical significance of up-regulated LncRNA NEAT1 in prognosis of ovarian cancer. Eur Rev Med Pharmacol Sci. 2016;20(16):3373\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"38","key":"2015_CR157","doi-asserted-by":"publisher","first-page":"62927","DOI":"10.18632\/oncotarget.17757","volume":"8","author":"F Liu","year":"2017","unstructured":"Liu F, Chen N, Gong Y, Xiao R, Wang W, Pan Z. The long non-coding RNA NEAT1 enhances epithelial-to-mesenchymal transition and chemoresistance via the miR-34a\/c-Met axis in renal cell carcinoma. Oncotarget. 2017;8(38):62927.","journal-title":"Oncotarget"},{"issue":"3","key":"2015_CR158","first-page":"504","volume":"21","author":"S Sun","year":"2017","unstructured":"Sun S, Lin Q, Ma J, Shi W, Yang B, Li F. Long non-coding RNA NEAT1 acts as oncogene in NSCLC by regulating the Wnt signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21(3):504\u201310.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2015_CR159","unstructured":"Zhang M, Wu W-B, Wang Z-W, Wang X-H. LncRNA NEAT1 is closely related with progression of breast cancer via promoting proliferation and EMT. Eur Rev Med Pharmacol Sci. 2017;21(5):1020-1026."},{"issue":"34","key":"2015_CR160","doi-asserted-by":"publisher","first-page":"12241","DOI":"10.3748\/wjg.v20.i34.12241","volume":"20","author":"P Zhang","year":"2014","unstructured":"Zhang P, Ji D-B, Han H-B, Shi Y-F, Du C-Z, Gu J. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer. World J Gastroenterology: WJG. 2014;20(34):12241.","journal-title":"World J Gastroenterology: WJG"},{"issue":"6","key":"2015_CR161","doi-asserted-by":"publisher","first-page":"4779","DOI":"10.3892\/ol.2016.5229","volume":"12","author":"Y Yi","year":"2016","unstructured":"Yi Y, Chen J, Jiao C, Zhong J, Song Z, Yu X, et al. Upregulated miR-193a-3p as an oncogene in esophageal squamous cell carcinoma regulating cellular proliferation, migration and apoptosis. Oncol Lett. 2016;12(6):4779\u201384.","journal-title":"Oncol Lett"},{"issue":"11","key":"2015_CR162","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.neo.2014.09.001","volume":"16","author":"JR Prensner","year":"2014","unstructured":"Prensner JR, Chen W, Han S, Iyer MK, Cao Q, Kothari V, et al. The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc. Neoplasia. 2014;16(11):900\u20138.","journal-title":"Neoplasia"},{"key":"2015_CR163","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11010-017-3177-8","volume":"441","author":"L Qiao","year":"2018","unstructured":"Qiao L, Liu X, Tang Y, Zhao Z, Zhang J, Liu H. Knockdown of long non-coding RNA prostate cancer-associated NcRNA transcript 1 inhibits multidrug resistance and c-Myc-dependent aggressiveness in colorectal cancer Caco-2 and HT-29 cells. Mol Cell Biochem. 2018;441:99\u2013108.","journal-title":"Mol Cell Biochem"},{"issue":"10","key":"2015_CR164","first-page":"18482","volume":"8","author":"B Zhao","year":"2015","unstructured":"Zhao B, Hou X, Zhan H. Long non-coding RNA PCAT-1 over-expression promotes proliferation and metastasis in non-small cell lung cancer cells. Int J Clin Exp Med. 2015;8(10):18482.","journal-title":"Int J Clin Exp Med"},{"issue":"4","key":"2015_CR165","first-page":"4126","volume":"8","author":"T-H Yan","year":"2015","unstructured":"Yan T-H, Yang H, Jiang J-H, Lu S-W, Peng C-X, Que H-X, et al. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma. Int J Clin Exp Pathol. 2015;8(4):4126.","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"2015_CR166","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3233\/CBM-160158","volume":"18","author":"X Shen","year":"2017","unstructured":"Shen X, Zhang Y, Wu X, Guo Y, Shi W, Qi J, et al. Upregulated lncRNA-PCAT1 is closely related to clinical diagnosis of multiple myeloma as a predictive biomarker in serum. Cancer Biomarkers. 2017;18(3):257\u201363.","journal-title":"Cancer Biomarkers"},{"issue":"1","key":"2015_CR167","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/cbf.3314","volume":"36","author":"Q Zhen","year":"2018","unstructured":"Zhen Q, Gao Ln W, Rf C, Ww Z, Yx Z, Xj, et al. LncRNA PCAT-1 promotes tumour growth and chemoresistance of oesophageal cancer to cisplatin. Cell Biochem Funct. 2018;36(1):27\u201333.","journal-title":"Cell Biochem Funct"},{"issue":"4","key":"2015_CR168","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1016\/j.bbrc.2017.12.157","volume":"495","author":"J Huang","year":"2018","unstructured":"Huang J, Deng G, Liu T, Chen W, Zhou Y. Long noncoding RNA PCAT-1 acts as an oncogene in osteosarcoma by reducing p21 levels. Biochem Biophys Res Commun. 2018;495(4):2622\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"2015_CR169","doi-asserted-by":"crossref","unstructured":"Zhang X, Zhang Y, Mao Y, Ma X. The LncRNA PCAT1 is correlated with poor prognosis and promotes cell proliferation, invasion, migration and EMT in osteosarcoma. OncoTargets Therapy. 2018;11:629\u201338.","DOI":"10.2147\/OTT.S152063"},{"issue":"7","key":"2015_CR170","first-page":"1907","volume":"22","author":"T Ma","year":"2018","unstructured":"Ma T, Zhou L, Xia J, Shen Y, Yan Y, Zhu R. LncRNA PCAT-1 regulates the proliferation, metastasis and invasion of cervical cancer cells. Eur Rev Med Pharmacol Sci. 2018;22(7):1907\u201313.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2015_CR171","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.biopha.2017.07.025","volume":"94","author":"F Zhang","year":"2017","unstructured":"Zhang F, Wan M, Xu Y, Li Z, Leng K, Kang P, et al. Long noncoding RNA PCAT1 regulates extrahepatic cholangiocarcinoma progression via the Wnt\/\u03b2-catenin-signaling pathway. Biomed Pharmacother. 2017;94:55\u201362.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"2015_CR172","first-page":"185","volume":"11","author":"S Sarrafzadeh","year":"2017","unstructured":"Sarrafzadeh S, Geranpayeh L, Ghafouri-Fard S. Expression analysis of long non-coding PCAT-1in breast cancer. Int J hematology-oncology Stem Cell Res. 2017;11(3):185.","journal-title":"Int J hematology-oncology Stem Cell Res"},{"key":"2015_CR173","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.12659\/MSM.900205","volume":"23","author":"P Su","year":"2017","unstructured":"Su P, Wang F, Qi B, Wang T, Zhang S. P53 regulation-association long non-coding RNA (LncRNA PRAL) inhibits cell proliferation by regulation of P53 in human lung cancer. Med Sci Monitor: Int Med J Experimental Clin Res. 2017;23:1751.","journal-title":"Med Sci Monitor: Int Med J Experimental Clin Res"},{"issue":"3","key":"2015_CR174","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/hep.28393","volume":"63","author":"F Zhou Cc, Yang","year":"2016","unstructured":"Zhou Cc, Yang F, Yuan Sx M, Jz, Liu F, Yuan Jh, et al. Systemic genome screening identifies the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinoma. Hepatology. 2016;63(3):850\u201363.","journal-title":"Hepatology"},{"issue":"2","key":"2015_CR175","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.yexcr.2018.06.026","volume":"370","author":"G Xiao","year":"2018","unstructured":"Xiao G, Li Y, Wang Y, Zhao B, Zou Z, Hou S, et al. LncRNA PRAL is closely related to clinical prognosis of multiple myeloma and the bortezomib sensitivity. Exp Cell Res. 2018;370(2):254\u201363.","journal-title":"Exp Cell Res"},{"issue":"10","key":"2015_CR176","doi-asserted-by":"publisher","first-page":"e0185720","DOI":"10.1371\/journal.pone.0185720","volume":"12","author":"C Lagler","year":"2017","unstructured":"Lagler C, El-Mesery M, K\u00fcbler AC, M\u00fcller-Richter UDA, St\u00fchmer T, Nickel J, et al. The anti-myeloma activity of bone morphogenetic protein 2 predominantly relies on the induction of growth arrest and is apoptosis-independent. PLoS ONE. 2017;12(10):e0185720.","journal-title":"PLoS ONE"},{"key":"2015_CR177","doi-asserted-by":"crossref","unstructured":"Zhang Y, Li W, Cao X, Mao J, Zhou X, Liu L et al. LncRNA H19-Encoded micropeptide altH19 promotes DNA replication and mitosis in myeloma cells by enhancing the phosphorylation of CDK2 at threonine 160. Cell Prolif. 2025:e70089.","DOI":"10.1111\/cpr.70089"},{"issue":"5","key":"2015_CR178","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3390\/cancers16051033","volume":"16","author":"M Dubaj","year":"2024","unstructured":"Dubaj M, Bigosi\u0144ski K, Dembowska A, Mlak R, Szudy-Szczyrek A, Ma\u0142ecka-Massalska T, et al. Role of non-coding RNAs in diagnosis, prediction and prognosis of multiple myeloma. Cancers. 2024;16(5):1033.","journal-title":"Cancers"},{"issue":"8","key":"2015_CR179","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.3390\/cancers14081963","volume":"14","author":"I Saltarella","year":"2022","unstructured":"Saltarella I, Apollonio B, Lamanuzzi A, Desantis V, Mariggi\u00f2 MA, Desaphy J-F, et al. The landscape of LncRNAs in multiple myeloma: implications in the hallmarks of cancer, clinical perspectives and therapeutic opportunities. Cancers. 2022;14(8):1963.","journal-title":"Cancers"},{"issue":"8","key":"2015_CR180","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.3390\/cancers13081976","volume":"13","author":"A Carrasco-Leon","year":"2021","unstructured":"Carrasco-Leon A, Amundarain A, Gomez-Echarte N, Prosper F, Agirre X. The role of LncRNAs in the pathobiology and clinical behavior of multiple myeloma. Cancers. 2021;13(8):1976.","journal-title":"Cancers"},{"key":"2015_CR181","doi-asserted-by":"crossref","unstructured":"Mishra R, Bagwill K, Gonzales S, Brizuela V, Thunuguntla P, Chang YJ, et al. Long Non-Coding RNA LINC00XPRR is upregulated in newly diagnosed multiple myeloma promoting poor response to High-Dose Melphalan with autologous stem cell transplantation and Three-Drug regimen. American Society of Hematology Washington, DC; 2023.","DOI":"10.1182\/blood-2023-180011"},{"issue":"10","key":"2015_CR182","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1038\/s41375-018-0104-2","volume":"32","author":"Y Hu","year":"2018","unstructured":"Hu Y, Lin J, Fang H, Fang J, Li C, Chen W, et al. Targeting the MALAT1\/PARP1\/LIG3 complex induces DNA damage and apoptosis in multiple myeloma. Leukemia. 2018;32(10):2250\u201362.","journal-title":"Leukemia"},{"issue":"1","key":"2015_CR183","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11912-024-01623-5","volume":"27","author":"N Mehra","year":"2025","unstructured":"Mehra N, Sundaram S, Shah P, Rao AKDM. Epigenetic role of long Non-coding RNAs in multiple myeloma. Curr Oncol Rep. 2025;27(1):37\u201344.","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"2015_CR184","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13036-023-00347-7","volume":"17","author":"J Escriv\u00e1-Fern\u00e1ndez","year":"2023","unstructured":"Escriv\u00e1-Fern\u00e1ndez J, Cueto-Ure\u00f1a C, Solana-Orts A, Lled\u00f3 E, Ballester-Lurbe B, Poch E. A CRISPR interference strategy for gene expression Silencing in multiple myeloma cell lines. J Biol Eng. 2023;17(1):34.","journal-title":"J Biol Eng"},{"issue":"1","key":"2015_CR185","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/biom14010083","volume":"14","author":"M Yang","year":"2024","unstructured":"Yang M, Chen Y, Zhu L, You L, Tong H, Meng H, et al. Harnessing nanotechnology: emerging strategies for multiple myeloma therapy. Biomolecules. 2024;14(1):83.","journal-title":"Biomolecules"},{"key":"2015_CR186","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.biochi.2016.06.007","volume":"131","author":"EM Smekalova","year":"2016","unstructured":"Smekalova EM, Kotelevtsev YV, Leboeuf D, Shcherbinina EY, Fefilova AS, Zatsepin TS, et al. LncRNA in the liver: prospects for fundamental research and therapy by RNA interference. Biochimie. 2016;131:159\u201372.","journal-title":"Biochimie"},{"issue":"5","key":"2015_CR187","first-page":"655","volume":"64","author":"X Pan","year":"2018","unstructured":"Pan X, Zheng G, Gao C. LncRNA PVT1: a novel therapeutic target for cancers. Clin Lab. 2018;64(5):655\u201362.","journal-title":"Clin Lab"},{"issue":"4","key":"2015_CR188","doi-asserted-by":"publisher","first-page":"e14489","DOI":"10.1111\/cns.14489","volume":"30","author":"WW Duan","year":"2024","unstructured":"Duan WW, Yang LT, Liu J, Dai ZY, Wang ZY, Zhang H, et al. A TGF-\u03b2 signaling\u2010related LncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response. CNS Neurosci Ther. 2024;30(4):e14489.","journal-title":"CNS Neurosci Ther"},{"issue":"40","key":"2015_CR189","doi-asserted-by":"publisher","first-page":"7314","DOI":"10.1002\/adfm.201603041","volume":"26","author":"Y Ren","year":"2016","unstructured":"Ren Y, Li RQ, Cai YR, Xia T, Yang M, Xu FJ. Effective codelivery of LncRNA and pDNA by pullulan-based nanovectors for promising therapy of hepatocellular carcinoma. Adv Funct Mater. 2016;26(40):7314\u201325.","journal-title":"Adv Funct Mater"},{"issue":"4","key":"2015_CR190","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1002\/1878-0261.12875","volume":"15","author":"AM Herrera-Solorio","year":"2021","unstructured":"Herrera-Solorio AM, Peralta\u2010Arrieta I, Armas Lopez L, Hern\u00e1ndez\u2010Cigala N, Mendoza Milla C, Ortiz Quintero B, et al. LncRNA SOX2\u2010OT regulates AKT\/ERK and SOX2\/GLI\u20101 expression, hinders therapy, and worsens clinical prognosis in malignant lung diseases. Mol Oncol. 2021;15(4):1110\u201329.","journal-title":"Mol Oncol"},{"issue":"3","key":"2015_CR191","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3892\/ijmm.2017.2888","volume":"39","author":"J-Q Pan","year":"2017","unstructured":"Pan J-Q, Zhang Y-Q, Wang J-H, Xu P, Wang W. LncRNA co-expression network model for the prognostic analysis of acute myeloid leukemia. Int J Mol Med. 2017;39(3):663\u201371.","journal-title":"Int J Mol Med"},{"key":"2015_CR192","doi-asserted-by":"publisher","first-page":"153303382094581","DOI":"10.1177\/1533033820945815","volume":"19","author":"C He","year":"2020","unstructured":"He C, Wang X, Luo J, Ma Y, Yang Z. Long noncoding RNA maternally expressed gene 3 is downregulated, and its insufficiency correlates with poor-risk stratification, worse treatment response, as well as unfavorable survival data in patients with acute myeloid leukemia. Technol Cancer Res Treat. 2020;19:1533033820945815.","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"2015_CR193","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13148-019-0643-z","volume":"11","author":"ZP Sellers","year":"2019","unstructured":"Sellers ZP, Bolkun L, Kloczko J, Wojtaszewska ML, Lewandowski K, Moniuszko M, et al. Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival. Clin Epigenetics. 2019;11(1):50.","journal-title":"Clin Epigenetics"},{"issue":"5","key":"2015_CR194","doi-asserted-by":"publisher","first-page":"7477","DOI":"10.18632\/oncotarget.13936","volume":"8","author":"M Ouimet","year":"2016","unstructured":"Ouimet M, Drouin S, Lajoie M, Caron M, St-Onge P, Gioia R, et al. A childhood acute lymphoblastic leukemia-specific LncRNA implicated in prednisolone resistance, cell proliferation, and migration. Oncotarget. 2016;8(5):7477.","journal-title":"Oncotarget"},{"issue":"12","key":"2015_CR195","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.3324\/haematol.2014.115683","volume":"99","author":"K Durinck","year":"2014","unstructured":"Durinck K, Wallaert A, Van de Walle I, Van Loocke W, Volders P-J, Vanhauwaert S, et al. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia. Haematologica. 2014;99(12):1808.","journal-title":"Haematologica"},{"issue":"4","key":"2015_CR196","doi-asserted-by":"publisher","first-page":"320","DOI":"10.5045\/br.2018.53.4.320","volume":"53","author":"A Ahmadi","year":"2018","unstructured":"Ahmadi A, Kaviani S, Yaghmaie M, Pashaiefar H, Ahmadvand M, Jalili M, et al. Altered expression of MALAT1 LncRNA in chronic lymphocytic leukemia patients, correlation with cytogenetic findings. Blood Res. 2018;53(4):320.","journal-title":"Blood Res"},{"issue":"5","key":"2015_CR197","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3906\/biy-1801-46","volume":"42","author":"N Yazdi","year":"2018","unstructured":"Yazdi N, Houshmand M, Atashi A, Kazemi A, Najmedini AA, Zarif MN. Long noncoding RNA PVT1: potential oncogene in the development of acutelymphoblastic leukemia. Turkish J Biology. 2018;42(5):405\u201313.","journal-title":"Turkish J Biology"},{"issue":"1","key":"2015_CR198","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12943-018-0884-z","volume":"17","author":"C Zeng","year":"2018","unstructured":"Zeng C, Liu S, Lu S, Yu X, Lai J, Wu Y, et al. The c-Myc-regulated LncRNA NEAT1 and paraspeckles modulate imatinib-induced apoptosis in CML cells. Mol Cancer. 2018;17(1):130.","journal-title":"Mol Cancer"},{"issue":"1","key":"2015_CR199","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1186\/1471-2407-14-693","volume":"14","author":"C Zeng","year":"2014","unstructured":"Zeng C, Xu Y, Xu L, Yu X, Cheng J, Yang L, et al. Inhibition of long non-coding RNA NEAT1 impairs myeloid differentiation in acute promyelocytic leukemia cells. BMC Cancer. 2014;14(1):693.","journal-title":"BMC Cancer"},{"issue":"1","key":"2015_CR200","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13045-018-0673-6","volume":"11","author":"NK Wong","year":"2018","unstructured":"Wong NK, Huang C-L, Islam R, Yip SP. Long non-coding RNAs in hematological malignancies: translating basic techniques into diagnostic and therapeutic strategies. J Hematol Oncol. 2018;11(1):131.","journal-title":"J Hematol Oncol"},{"issue":"12","key":"2015_CR201","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1080\/15476286.2021.1899500","volume":"18","author":"S Zibitt","year":"2021","unstructured":"Zibitt S, Hartford M, Lal CCR. Interrogating LncRNA functions via CRISPR\/Cas systems. RNA Biol. 2021;18(12):2097\u2013106.","journal-title":"RNA Biol"},{"key":"2015_CR202","doi-asserted-by":"publisher","first-page":"1242129","DOI":"10.3389\/fgene.2023.1242129","volume":"14","author":"QR Lyu","year":"2023","unstructured":"Lyu QR, Zhang S, Zhang Z, Tang Z. Functional knockout of long non-coding RNAs with genome editing. Front Genet. 2023;14:1242129.","journal-title":"Front Genet"},{"issue":"1","key":"2015_CR203","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12943-022-01518-8","volume":"21","author":"SW Wang","year":"2022","unstructured":"Wang SW, Gao C, Zheng YM, Yi L, Lu JC, Huang XY, et al. Current applications and future perspective of CRISPR\/Cas9 gene editing in cancer. Mol Cancer. 2022;21(1):57.","journal-title":"Mol Cancer"},{"issue":"1","key":"2015_CR204","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s13205-024-04186-1","volume":"15","author":"H Fatima","year":"2025","unstructured":"Fatima H, Singh D, Muhammad H, Acharya S, Aziz MA. Improving the use of CRISPR\/Cas9 gene editing machinery as a cancer therapeutic tool with the help of nanomedicine. 3 Biotech. 2025;15(1):17.","journal-title":"3 Biotech"},{"issue":"16","key":"2015_CR205","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1182\/blood.2023021991","volume":"144","author":"K Grillone","year":"2024","unstructured":"Grillone K, Ascrizzi S, Cremaschi P, Amato J, Poler\u00e0 N, Croci O, et al. An unbiased LncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8. 5 as a novel therapeutic target for multiple myeloma. Blood. 2024;144(16):1705\u201321.","journal-title":"Blood"},{"issue":"6","key":"2015_CR206","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/s41375-020-01034-y","volume":"35","author":"A David","year":"2021","unstructured":"David A, Zocchi S, Talbot A, Choisy C, Ohnona A, Lion J, et al. The long non-coding RNA CRNDE regulates growth of multiple myeloma cells via an effect on IL6 signalling. Leukemia. 2021;35(6):1710\u201321.","journal-title":"Leukemia"},{"issue":"12","key":"2015_CR207","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/nbt.3715","volume":"34","author":"S Zhu","year":"2016","unstructured":"Zhu S, Li W, Liu J, Chen CH, Liao Q, Xu P, et al. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library. Nat Biotechnol. 2016;34(12):1279\u201386.","journal-title":"Nat Biotechnol"},{"issue":"14","key":"2015_CR208","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.7150\/ijms.45706","volume":"17","author":"LC Lin","year":"2020","unstructured":"Lin LC, Lee HT, Chien PJ, Huang YH, Chang MY, Lee YC, et al. NAD(P)H:quinone oxidoreductase 1 determines radiosensitivity of triple negative breast cancer cells and is controlled by long non-coding RNA NEAT1. Int J Med Sci. 2020;17(14):2214\u201324.","journal-title":"Int J Med Sci"},{"issue":"1","key":"2015_CR209","doi-asserted-by":"publisher","first-page":"8155","DOI":"10.1038\/s41467-025-63256-x","volume":"16","author":"K Deka","year":"2025","unstructured":"Deka K, Carter J-M, Bahai A, Ang DA, Sim N, Chong HY, et al. Multiple myeloma associated long non-coding RNA PLUM confers chemoresistance by enhancing PRC2 mediated UPR pathway activation. Nat Commun. 2025;16(1):8155.","journal-title":"Nat Commun"},{"issue":"1","key":"2015_CR210","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13059-016-1012-2","volume":"17","author":"M Haeussler","year":"2016","unstructured":"Haeussler M, Sch\u00f6nig K, Eckert H, Eschstruth A, Miann\u00e9 J, Renaud J-B, et al. Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR. Genome Biol. 2016;17(1):148.","journal-title":"Genome Biol"},{"key":"2015_CR211","doi-asserted-by":"crossref","unstructured":"McHugh CA, Guttman M. RAP-MS: a method to identify proteins that interact directly with a specific RNA molecule in cells. RNA detection: methods and protocols. Springer; 2018. pp. 473\u201388.","DOI":"10.1007\/978-1-4939-7213-5_31"},{"issue":"1","key":"2015_CR212","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41467-023-36345-y","volume":"14","author":"RA Cordiner","year":"2023","unstructured":"Cordiner RA, Dou Y, Thomsen R, Bugai A, Granneman S, Heick Jensen T. Temporal-iCLIP captures co-transcriptional RNA-protein interactions. Nat Commun. 2023;14(1):696.","journal-title":"Nat Commun"},{"issue":"7","key":"2015_CR213","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1038\/s41596-021-00555-9","volume":"16","author":"H-P Chu","year":"2021","unstructured":"Chu H-P, Minajigi A, Chen Y, Morris R, Guh C-Y, Hsieh Y-H, et al. iDRiP for the systematic discovery of proteins bound directly to noncoding RNA. Nat Protoc. 2021;16(7):3672\u201394.","journal-title":"Nat Protoc"},{"issue":"2","key":"2015_CR214","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cell.2015.03.025","volume":"161","author":"C Chu","year":"2015","unstructured":"Chu C, Zhang QC, da Rocha ST, Flynn RA, Bharadwaj M, Calabrese JM, et al. Systematic discovery of Xist RNA binding proteins. Cell. 2015;161(2):404\u201316.","journal-title":"Cell"},{"key":"2015_CR215","doi-asserted-by":"crossref","unstructured":"Chu C, Chang HY, ChIRP-MS. RNA-directed proteomic discovery. X-Chromosome inactivation: methods and protocols. Springer; 2018. pp. 37\u201345.","DOI":"10.1007\/978-1-4939-8766-5_3"},{"key":"2015_CR216","unstructured":"Brittany R, Elizabeth M, Rachel C, Kara O, Elisabeth W, Rachel S. Kinetics and Thermodynamics of DNA, RNA, and Hybrid Duplex Formation. 2013."},{"issue":"7","key":"2015_CR217","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1038\/s41596-019-0172-4","volume":"14","author":"B Zhou","year":"2019","unstructured":"Zhou B, Li X, Luo D, Lim D-H, Zhou Y, Fu X-D. GRID-seq for comprehensive analysis of global RNA\u2013chromatin interactions. Nat Protoc. 2019;14(7):2036\u201368.","journal-title":"Nat Protoc"},{"issue":"1","key":"2015_CR218","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/s41467-020-14337-6","volume":"11","author":"A Bonetti","year":"2020","unstructured":"Bonetti A, Agostini F, Suzuki AM, Hashimoto K, Pascarella G, Gimenez J, et al. RADICL-seq identifies general and cell type\u2013specific principles of genome-wide RNA-chromatin interactions. Nat Commun. 2020;11(1):1018.","journal-title":"Nat Commun"},{"issue":"7812","key":"2015_CR219","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41586-020-2249-1","volume":"582","author":"Z Cai","year":"2020","unstructured":"Cai Z, Cao C, Ji L, Ye R, Wang D, Xia C, et al. RIC-seq for global in situ profiling of RNA\u2013RNA Spatial interactions. Nature. 2020;582(7812):432\u20137.","journal-title":"Nature"},{"issue":"23","key":"2015_CR220","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.1016\/j.cell.2021.10.014","volume":"184","author":"SA Quinodoz","year":"2021","unstructured":"Quinodoz SA, Jachowicz JW, Bhat P, Ollikainen N, Banerjee AK, Goronzy IN, et al. RNA promotes the formation of Spatial compartments in the nucleus. Cell. 2021;184(23):5775\u201390. e30.","journal-title":"Cell"},{"key":"2015_CR221","doi-asserted-by":"crossref","unstructured":"Aguilar R, Mardones C, Moreno AA, Cepeda-Plaza M. A guide to RNA structure analysis and RNA\u2010targeting methods. FEBS J. 2025;292(11):2751-2766..","DOI":"10.1111\/febs.17368"},{"key":"2015_CR222","doi-asserted-by":"crossref","unstructured":"Ma WK, Voss DM, Scharner J, Costa AS, Lin K-T, Jeon HY et al. ASO-based PKM splice-switching therapy inhibits hepatocellular carcinoma cell growth. Cancer Res.2022;82(5):900-915.","DOI":"10.1158\/0008-5472.CAN-20-0948"},{"key":"2015_CR223","doi-asserted-by":"publisher","first-page":"225","DOI":"10.20517\/jtgg.2024.12","volume":"8","author":"P Tamblin-Hopper","year":"2024","unstructured":"Tamblin-Hopper P, Kiss-Toth E, Sudbery I, Young D, Wilkinson JM. The potential therapeutic applications of long non-coding RNAs. J Transl Genet Genom. 2024;8:225\u201343.","journal-title":"J Transl Genet Genom"},{"key":"2015_CR224","doi-asserted-by":"publisher","first-page":"116636","DOI":"10.1016\/j.lfs.2019.116636","volume":"232","author":"D Gupta","year":"2019","unstructured":"Gupta D, Bhattacharjee O, Mandal D, Sen MK, Dey D, Dasgupta A, et al. CRISPR-Cas9 system: A new-fangled dawn in gene editing. Life Sci. 2019;232:116636.","journal-title":"Life Sci"},{"issue":"1","key":"2015_CR225","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","volume":"88","author":"DM Pegtel","year":"2019","unstructured":"Pegtel DM, Gould SJ, Exosomes. Annu Rev Biochem. 2019;88(1):487\u2013514.","journal-title":"Annu Rev Biochem"},{"issue":"6","key":"2015_CR226","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00432-017-2361-2","volume":"143","author":"L Pan","year":"2017","unstructured":"Pan L, Liang W, Fu M, Huang Z-h, Li X, Zhang W, et al. Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression. J Cancer Res Clin Oncol. 2017;143(6):991\u20131004.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"2015_CR227","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.bbrc.2017.06.055","volume":"490","author":"R Zhang","year":"2017","unstructured":"Zhang R, Xia Y, Wang Z, Zheng J, Chen Y, Li X, et al. Serum long Non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in Non-small cell lung cancer. Biochem Biophys Res Commun. 2017;490(2):406\u201314.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2015_CR228","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12943-017-0714-8","volume":"16","author":"M Xue","year":"2017","unstructured":"Xue M, Chen W, Xiang A, Wang R, Chen H, Pan J, et al. Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1. Mol Cancer. 2017;16(1):143.","journal-title":"Mol Cancer"},{"issue":"1","key":"2015_CR229","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41392-020-0129-7","volume":"5","author":"C Ni","year":"2020","unstructured":"Ni C, Fang Q-Q, Chen W-Z, Jiang J-X, Jiang Z, Ye J, et al. Breast cancer-derived exosomes transmit LncRNA SNHG16 to induce CD73\u2009+\u2009\u03b3\u03b41 Treg cells. Signal Transduct Target Therapy. 2020;5(1):41.","journal-title":"Signal Transduct Target Therapy"},{"issue":"11","key":"2015_CR230","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41419-019-2077-0","volume":"10","author":"Z-x Liang","year":"2019","unstructured":"Liang Z-x, Liu H-s, Wang F-w, Xiong L, Zhou C, Hu T, et al. LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization. Cell Death Dis. 2019;10(11):829.","journal-title":"Cell Death Dis"},{"issue":"2","key":"2015_CR231","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1158\/1541-7786.MCR-23-0282","volume":"22","author":"Q-M Wang","year":"2024","unstructured":"Wang Q-M, Lian G-Y, Sheng S-M, Xu J, Ye L-L, Min C, et al. Exosomal LncRNA NEAT1 inhibits NK-cell activity to promote multiple myeloma cell immune escape via an EZH2\/PBX1 axis. Mol Cancer Res. 2024;22(2):125\u201336.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"2015_CR232","doi-asserted-by":"publisher","first-page":"6272498","DOI":"10.1155\/2020\/6272498","volume":"2020","author":"W Olejarz","year":"2020","unstructured":"Olejarz W, Dominiak A, \u017bo\u0142nierzak A, Kubiak-Tomaszewska G, Lorenc T. Tumor-derived exosomes in immunosuppression and immunotherapy. J Immunol Res. 2020;2020(1):6272498.","journal-title":"J Immunol Res"},{"key":"2015_CR233","doi-asserted-by":"publisher","first-page":"6527","DOI":"10.2147\/IJN.S388604","volume":"17","author":"S Wang","year":"2022","unstructured":"Wang S, Shi Y. Exosomes derived from immune cells: the new role of tumor immune microenvironment and tumor therapy. Int J Nanomed. 2022;17:6527.","journal-title":"Int J Nanomed"},{"issue":"5","key":"2015_CR234","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3892\/ol.2021.12638","volume":"21","author":"X Li","year":"2021","unstructured":"Li X, Liu Y, Zheng S, Zhang T, Wu J, Sun Y, et al. Role of exosomes in the immune microenvironment of ovarian cancer. Oncol Lett. 2021;21(5):377.","journal-title":"Oncol Lett"},{"issue":"1","key":"2015_CR235","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1158\/0008-5472.CAN-18-0014","volume":"79","author":"J Lan","year":"2019","unstructured":"Lan J, Sun L, Xu F, Liu L, Hu F, Song D, et al. M2 macrophage-derived exosomes promote cell migration and invasion in colon cancer. Cancer Res. 2019;79(1):146\u201358.","journal-title":"Cancer Res"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-02015-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-02015-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-02015-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T03:02:51Z","timestamp":1769569371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-02015-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,18]]},"references-count":235,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2015"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-02015-0","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,18]]},"assertion":[{"value":"4 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"114"}}